MRI in Diagnosing and Monitoring CIDP
- Conditions
- Chronic Inflammatory Demyelinating Polyradiculoneuropathy
- Registration Number
- NCT02017769
- Lead Sponsor
- University of Aarhus
- Brief Summary
We want to study whether MRI can be useful in diagnosing and monitoring patients with CIDP in maintenance treatment with immunoglobulin
- Detailed Description
Chronic inflammatory neuropathies such as chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) can be successfully treated with immunoglobulin either intravenously (IVIG) or subcutaneously (SCIG).
CIDP is diagnosed by electrophysiology which is time-consuming and unpleasant for the patient.
New techniques suggest that Magnetic Resonance Imaging (MRI) and ultrasound imaging can be used to detect injuries in the peripheral nerves
We want to study if MRI and ultrasound is able to detect damages in peripheral nerves, nerve roots and plexus in patients with CIDP.
Moreover, we want to compare these findings to healthy matched controls and to see if treatment with immunoglobulin changes findings in MRI
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 39
CIDP patients
- Age > 18 and < 80 years
- Diagnosed with definite and probable CIDP and fulfilling the European Federation of Neurological Sciences/Peripheral Nerve Society (EFNS/PNS) criteria
Healthy controls
- Age > 18 and < 80 years
- No neurological disorders
- Age < 18 or > 80 years
- Contraindications to MRI
- Pregnancy
- Other cause of neuropathy (incl. pressure neuropathy)
- Diabetes mellitus
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method DTI changes in nerves and muscles At enrolment Diffusion Tension Imaging (DTI) in peripheral nerves and muscles in the lower extremities in CIDP patients treated with SCIG will be compared to healthy controls
- Secondary Outcome Measures
Name Time Method Comparing clinical findings to MRI At enrolment Clinical evaluation by:
Isokinetic dynamometry Clinical MRC score
These findings wil be compared to findings on MRI to assess an eventual correlationChanges in MRI findings between treated and untreated CIDP patients All patients are examined at enrolment. Untreated patients are re-examined after 4 months of treatment Comparing changes in MTR and DTI between CIDP patients treated with subcutaneous immunoglobulin to those untreated.
The untreated patients will be examined again after 4 months of treatment with immunoglobulin
Trial Locations
- Locations (1)
Department of Neurology, Aarhus University Hospital
🇩🇰Aarhus, Denmark